Acrux Ltd 2023 Annual Report with Sustainability Disclosures
Company: Acrux Ltd
Sector: Manufacturing
Country: Australia
Year: 2023
Type: Annual Report with Sustainability Disclosures
Pages: 68
The report describes FY23 as a pivotal year for the company, marked by the US launch of Prilocaine and Lidocaine Cream, FDA approval of Dapsone Gel 5%, and further products progressing through FDA review. Reported revenue reached $11.928 million, up 134% on the prior year, supported by the Lenzetto royalty transaction and product growth. The ESG section organizes the company's responsible-business approach around environmental, social and governance tenets, including energy and waste reduction, employee safety and ethical conduct.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.